Lioton (Heparin Sodium)

• Lioton (heparin sodium) is an anticoagulant used in the management of thrombotic conditions affecting superficial veins.
• Prevention of thrombosis: reduces the risk of clot formation in patients with high thrombotic risk.
• Superficial thrombophlebitis treatment: alleviates inflammation and prevents progression of clot in superficial veins.
• Catheter‑related thrombosis prophylaxis: minimizes clot development at catheter insertion sites.

• Heparin sodium exerts its anticoagulant effect by binding to antithrombin III, markedly enhancing the inhibitor’s activity against thrombin (factor IIa) and factor Xa. This accelerated inhibition disrupts the conversion of fibrinogen to fibrin, thereby interrupting the coagulation cascade and preventing the formation and propagation of clots at the site of application. The localized delivery concentrates the effect on the skin and underlying tissues while limiting systemic absorption.

Topical application of heparin sodium may be associated with local and systemic adverse reactions.

Common Side Effects

• Skin irritation: redness or mild itching at the application site.
• Erythema: localized redness without swelling.
• Minor bruising: small areas of discoloration near the treated area.

Serious or Rare Side Effects

• Severe skin necrosis: tissue death at the site of application.
• Systemic bleeding: unexpected bleeding from other body sites.
• Heparin‑induced thrombocytopenia (HIT): immune‑mediated drop in platelet count.
• Anaphylactic reaction: rapid onset of allergic symptoms requiring emergency care.

• When using Lioton, consider the following precautions to ensure safe and effective therapy.
• Assess bleeding risk: evaluate patient history for hemorrhagic disorders before application.
• Avoid use on broken skin: apply only to intact, healthy skin to reduce systemic absorption.
• Concurrent anticoagulants: limit use with other systemic anticoagulant or antiplatelet drugs to prevent excessive bleeding.
• Monitor skin reactions: discontinue if severe irritation, rash, or necrosis develops.
• Pregnancy and lactation: consult a healthcare professional before use in pregnant or breastfeeding individuals.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Heparin sodium may interact with other medications, influencing anticoagulant effects.

Major Interactions (Avoid)

• Systemic anticoagulants (e.g., warfarin, direct oral anticoagulants): may cause uncontrolled bleeding.
• Thrombolytic agents (e.g., alteplase): increase risk of severe hemorrhage.
• Antiplatelet drugs (e.g., aspirin, clopidogrel): additive antithrombotic effect heightening bleeding risk.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): may modestly increase bleeding tendency.
• Corticosteroid creams: could enhance local skin thinning and irritation.
• Other topical agents: assess for additive skin reactions.